Overview
Japan is a world leader in technology innovation and R&D spending. For the past 20 years, Japan has also been a global leader in the discovery and development of new medicines. In this context, Finglobedirect, which has been providing company and financial information globally since two decades, brings out an analytical report - Japanese Life Sciences 300: Recent Growth and New Directions.

Objective
The objective of this report is to review and analyze the performance of the Japanese life science companies during the most recent 12 months based on financial data, business news, stock market returns, and other non-financial information not quantifiable.

Research Sources
Our research team has compiled financial information of Japanese life science companies throughout the year from reliable primary and secondary sources including company websites, press releases, and stock exchanges. Further, the business news have been compiled throughout the year from established news portals, regional and international primary news sources, business media sites, company websites and stock exchanges. Also, stock prices from global stock exchanges have been compiled to list out the top gainers/decliners of the year.

• Comprehensive focus on listed and non-listed Japanese life science companies as well as foreign MNC units in Japan
• Provides quarterly update with rolling 12 months of data to facilitate focused analysis
• Identifies the leading Japanese life science companies of most recent 12 months based on financial performance
• Presents the top gainers and bottom decliners of most recent 12 months on the basis of comparative stock analysis
• Summarizes business transactions of the leading Japanese life science companies during the most recent 12 months including transactions related to key products and brands
• Presents analytical observations based on the key business transactions summarized

• 1.1 Top 25 fastest growing Japanese life science companies
• 1.2 Top 25 most profitable Japanese life science companies
• 1.3 Top 25 most efficient Japanese life science companie
• 1.4 Leading most improved Japanese life science companies

• 2.1 Top 25 gainers/decliners each based on stock price changes compared to previous 12 months

• 3.1 Top 25 Japanese multinational life science companies
• 3.2 Leading Japanese life science companies with extensive global business

• 4.1 Top 25 Japanese research-intensive life science companies
• 4.2 Additional research-intensive Japanese life science companies based on R&D facilities

• 5.1: Major contracts/deals/agreements
• 5.2: Major mergers/acquisitions
• 5.3: Major expansions
• 5.4: Major joint ventures
• 5.5: Major new businesses
• 5.6: Major investments
• 5.7: Major management changes

• 6.1: Major regulatory approvals/patents received
• 6.2: Major new products launched
• 6.3: Major brands in news
• 6.4: Major patents or applications filed/submitted
• 6.5: Major innovations or research & development
• 6.6: Major patients’ studies in works as of December 31, 2015

• 9.1: Investment strategies, industry trends and foreign countries’ activities with Japan
• 9.2: Leading brands and products: Key news, industry trends and foreign countries involved
• 9.3: Current issues and challenges for Japanese life science companies
• 9.4: Future investments planned by Japanese life science companies

• Appendix 1: List of Listed Japanese Life Science Companies: By Company Name
• Appendix 2: List of Non-Listed Japanese Life Science Companies: By Company Name
• Appendix 3: List of Foreign Multinationals’ Units in Japan: By Region, Country, and Foreign Parent Company Name
• Appendix 4: List of Japanese Life Science Companies: By Industry and Company Name

• Company analysts with years of experience have analyzed the financial data and business transactions of the Japanese life science companies
• In-depth review and analysis of Japanese life science companies by various attributes
• An efficient process wherein same companies emerging as leading by various attributes are highlighted
• Reveals the leaders in the Japanese life science sector for most recent 12 months

Research Report: Japan Life Sciences Business 300: Recent Growth and New Directions: $500

Select Product Japan Life Sciences Business 300: Recent Growth and New Directions

Select Price $500

$850 for all three publications: Japan Life Sciences series on Analysis/Investors Presentations (savings of $245)

• Japan Life Sciences Business 300: Recent Growth and New Directions $500
• Japan Life Sciences 300: Analysis of Quarterly Earnings (ending September 30, 2015) $400
• Japan Life Sciences 300: Investor Presentations( 25 companies) $195

Select Product Japan Life Sciences Analysis series: 3 products

Select Price $850